5-Year Purchase Forecast for Abbott's Structural Heart Portfolio in Venezuela

Created using ChatSlide

This presentation outlines a comprehensive strategy for addressing cardiovascular trends in Venezuela, leveraging private healthcare to expand access. Covering a phased portfolio rollout, market analysis, and revenue projections with expected CAGR of ~35%, it highlights potential annual TAM of $55M-$120M. Key focuses include regulatory strategies, structural center expansion, and effective SG&A investments, targeting Year 5 profitability. Emphasis on transcatheter innovations aligns with...